LESLIE MCGRAW: Open Payments
NPI 1922074335 · YERINGTON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 17 payments from 11 companies in 2025. Trend: 2023 $108 · 2024 $361 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $141 |
| PFIZER INC. | 3 | $57 |
| ABBVIE INC. | 2 | $56 |
| Astellas Pharma US Inc | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, PREVNAR 20, VRAYLAR, Veozah, LEQVIO, GEMTESA, CAPVAXIVE, BEXSERO.
Industry payments across NV — which companies pay providers there.
